Clariant aims to start Cuddalore healthcare packaging facility in 2017

The company also plans to expand production by adding high-capacity multi-lane production line for its versatile Continu-Strip desiccant packets

Clariant's desiccant for pharma packaging
Clariant's desiccant for pharma packaging
Rakesh Rao Mumbai
Last Updated : Nov 22 2016 | 1:03 PM IST
Clariant, one of the leading global specialty chemicals companies, is planning to begin production of dessicant canisters from its new greenfield production facility in Cuddalore (Tamil Nadu) by the second semester of 2017. This plant will be a significant contributor to Clariant’s global desiccant canister production.

Clariant’s business line healthcare packaging had conducted the groundbreaking ceremony of this plant in January 2016. This facility will manufacture desiccant canisters - the primary desiccant platform for high-speed, high-volume packaging lines that are used by generic drug manufacturers. In addition, Clariant is also planning to expand production by adding high-capacity multi-lane production line for its versatile Continu-Strip desiccant packets, which can be inserted with numerous types of standard dessicant insertion machinery. 

“The new site will serve the Indian pharmaceutical industry with state-of-the-art desiccant products produced under the strictest quality and compliance standards, and within a secure, truly global manufacturing network. We are extremely excited that facility construction, and production plans are moving at full speed ahead, according to schedule. The production capabilities at this new facility will add significantly to our global dessicant canister production capacity during 2017,” said Matthias Brommer, head - Clariant Healthcare Packaging, during the CPhI 2016 trade show for pharmaceutical ingredients held in Mumbai from November 21-23, 2016.

Clariant's extensive manufacturing footprint ensures quick delivery and competitive pricing, as well back-up capacity to meet the BCP (business continuity planning) requirements of global players in the pharmaceutical industry. All products produced at the Cuddalore facility will meet US FDA and EU standards for use in pharmaceutical applications and will be USP compliant. The Cuddalore facility is equipped with an ISO Class 8 clean room and will implement GMPs and environmental controls with a path toward ISO 15378 certification.

Ketan Premani, head - healthcare packaging India, Clariant, added, “The facility will also offer the full range of globally produced Clariant protective packaging systems and components and link customers to Clariant’s global packaging design capabilities. The facility and the other healthcare packaging facilities around the globe ensure available back-up capacity to meet the BCP requirements of our global customers.”

Advanced canister mould and assembly designs ensure their ability to withstand the rigours of high speed insertion, packaging, and use. Coloured labelling - including bright red - is available to help differentiate desiccant canisters from drug products. 

Clariant Healthcare Packaging is one of the leading suppliers of pharmaceutical desiccants in India, with a long history of working with both branded and generic drug manufacturers. The Cuddalore facility, the latest in the rapidly expanding global manufacturing network through which Clariant Healthcare Packaging produces and delivers its desiccant and sorbent products, joins existing production facilities in the US, France and China. The new facility is strategically located within the Bengaluru-Chennai biopharmaceutical cluster, one of India’s busiest pharmaceutical hubs, and is positioned to leverage Clariant’s existing network and logistics resources to serve customers throughout India.  
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 22 2016 | 12:59 PM IST

Next Story